Our Company’s research and development and pharmaceutical operations are managed in a matrix organization and in accordance with the procedures defined in our quality system.

In order to carry out in-house research and development programs successfully, we have specific scientific expertise in the field of immunopharmacology and skills for steering complex programs involving many disciplines, which we largely implement through subcontracting and collaboration agreements.

To ensure control over our principal operational processes, compliance with regulations applicable to our activities and the availability of adequate resources to achieve our research and development objectives, we have implemented a quality policy based on the ISO 9001:2000 certification obtained in 2005 and renewed annually ever since.

We believe that our ability to manage multi-disciplinary research and development programs in a coordinated, flexible and responsive way, integrating in-house research and subcontracting, gives us a significant competitive advantage.